Automation in Nuclear Cardiology: Time for Flurpiridaz to Join the Club

Ahmed Aljizeeri^{1

2

3}, Firas Al Badarin⁴, Mouaz H Al-Mallah⁵

Affiliations

¹ King Abdulaziz Cardiac Center, Riyadh, Kingdom of Saudi Arabia.
² King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
³ King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.
⁴ Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
⁵ Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, 6550 Fannin Street, Smith Tower - Suite 1801, Houston, TX, 77030, USA. mouaz74@gmail.com.

Editorial

Ahmed Aljizeeri et al. J Nucl Cardiol. 2022 Apr.

. 2022 Apr;29(2):709-711.

doi: 10.1007/s12350-020-02421-9. Epub 2020 Nov 17.

Ahmed Aljizeeri^{1

2

3}, Firas Al Badarin⁴, Mouaz H Al-Mallah⁵

¹ King Abdulaziz Cardiac Center, Riyadh, Kingdom of Saudi Arabia.
² King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
³ King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia.
⁴ Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
⁵ Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, 6550 Fannin Street, Smith Tower - Suite 1801, Houston, TX, 77030, USA. mouaz74@gmail.com.

No abstract available

Comment on

Development, diagnostic performance, and interobserver agreement of a ¹⁸F-flurpiridaz PET automated perfusion quantitation system.
Packard RRS, Cooke CD, Van Train KF, Votaw JR, Sayre JW, Lazewatsky JL, Champagne KM, Orlandi C, Garcia EV, Maddahi J. Packard RRS, et al. J Nucl Cardiol. 2022 Apr;29(2):698-708. doi: 10.1007/s12350-020-02335-6. Epub 2020 Sep 7. J Nucl Cardiol. 2022. PMID: 32895856 Free PMC article.

1. Bateman TM, Dilsizian V, Beanlands RS, DePuey EG, Heller GV, Wolinsky DA. American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET. J Nucl Med. 2016;57:1654–6. - DOI
1. Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions. Heart Fail Rev. 2017;22:441–53. - DOI
1. Al-Mallah MH, Sitek A, Moore SC, Di Carli M, Dorbala S. Assessment of myocardial perfusion and function with PET and PET/CT. J Nucl Cardiol. 2010;17:498–513. - DOI
1. Yu M, Nekolla SG, Schwaiger M, Robinson SP. The next generation of cardiac positron emission tomography imaging agents: Discovery of flurpiridaz F-18 for detection of coronary disease. Semi. Nucl Med. 2011;41:305–13. - DOI
1. Maddahi J. Properties of an ideal PET perfusion tracer: New PET tracer cases and data. J Nucl Cardiol. 2012;19:S30–7. - DOI